Renal Cell Carcinoma (RCC)
Oncology·MeSH: Recurrence
Prevalence
48.0 / 100K
Incidence
15.0 / 100K/yr
13 drugs in development·9 companies·10 clinical trials
Drug Pipeline by Phase
Approved(4)
Phase 3(4)
Phase 1(4)
Preclinical(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Renal Cell Carcinoma (RCC)?
BioSniper tracks 13 drugs in development for Renal Cell Carcinoma (RCC) across 9 companies.
How many clinical trials target Renal Cell Carcinoma (RCC)?
There are 10 clinical trials targeting Renal Cell Carcinoma (RCC) tracked by BioSniper.
What is the prevalence of Renal Cell Carcinoma (RCC)?
The estimated prevalence of Renal Cell Carcinoma (RCC) is approximately 48.0 per 100,000 population.
Deep-dive into Renal Cell Carcinoma (RCC)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis